CMS Announces URAC’s Initial Approval as Recognized Home Infusion Therapy Supplier Accreditor

Approved symbol

WASHINGTON – CMS has announced URAC’s initial approval as a recognized home infusion therapy supplier accreditor for a period of 4 years effective March 27, 2020 – March 27, 2024. A final notice was published in the Federal Register announcing URAC’s approval on April 1, 2020.

URAC’s Medicare Home Infusion Therapy Supplier (MHITS) Accreditation Standards are mapped to CMS requirements with additional standards based on industry best practices related to handling of complex pharmaceutical and/or nutritional products, comprehensive patient management, ongoing monitoring to ensure patient safety, coordination of patient care with multidisciplinary care team, business continuity, emergency management and regulatory compliance.

Home infusion therapy suppliers that obtain accreditation from a CMS-recognized accreditation organization such as URAC are eligible to be reimbursed under Medicare’s new home infusion therapy benefit starting in 2021 as authorized under the 21st Century Cures Act.

“URAC is pleased that CMS has recognized our pharmacy-focused MHITS accreditation program with deemed status,” said Heather Bonome, PharmD, URAC’s Pharmacy Director. “Since infusion therapy is occurring more frequently in a home setting, it was a natural progression to apply URAC’s expertise to home infusion pharmacy practice,” she continued. “Our program highlights the leadership role that pharmacy plays in infusion pharmacy while emphasizing the critical importance of collaborating with the multidisciplinary health care team to provide high-quality education, administration, and monitoring to home infusion patients.”

Shawn Griffin, M.D., President and CEO added, “as the premier accreditor of pharmacy quality management, we are very proud to receive approval from CMS as a recognized home infusion therapy supplier accreditation organization. It’s nice to know that in our thirtieth year, we are still building accreditation programs focused on advancing quality and improving patient care.” Dr. Griffin concluded by stating “this recognition is the first time URAC has received formal recognition in the Medicare provider suite which is a testament to the expertise of our teams, our open development process, and our dedication to highlighting excellence in care delivery.”